Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome

References

• Stein I F., Leventhal M L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181
   Google Scholar
• Goldzieher J W. Polycystic ovarian disease. Fertil Steril 1981; 35: 371
   PubMed Web of Science ®Google Scholar
• Yen S SC. The polycystic ovary syndrome. Clin Endo-crinol (Oxf) 1980; 12: 177
   PubMed Web of Science ®Google Scholar
• Katz M. Polycystic ovaries. Clinics in Obstetrics and Gynecology 1981; 8(3)715
   Google Scholar
• Andersson R N., Givens J R., Weiser W L., Umstot E S. Response of the binding capacity of plasma testoste-rone-estradiol-binding globulin to norethindrone and mestranol 0.1 mg in polycystic ovarian disease. Am J Obstet Gynecol 1976; 125: 166
   Google Scholar
• Shailaja G R., Madhwa H GR, Talbert L M., Sloan C, Hicks B. Normalization of testosterone levels using a low estrogen containing oral contraceptive in women with polycystic ovary syndrome. Obstet Gynecol 1982; 60(1)15
   Google Scholar
• Cullberg G, Dovré P A., Lindstedt G, Steffensen K. On the use of plasma proteins as indicators of the metabolic effects of combined oral contraceptives. Acta Obstet Gynecol Scand 1982, Suppl. 111: 47
   Google Scholar
• Bergink E W., Holma P, Pyörälä T. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. Scand J Clin Lab Invest 1981; 41: 663
   PubMed Web of Science ®Google Scholar
• Lorenzo E M. Familial study of hirsutism. J Clin Endo-crinol 1970; 31: 556
   PubMed Web of Science ®Google Scholar
• Lindner H R., Bauminger S. Recent Progress in Reproductive Endocrinology, P G. Crossignani, V HT James. Academic Press, New York 1974; 193
   Google Scholar
• Mikhail G, Wu C H., Ferein M. Radioimmunoassay of plasma estrone and estradiol. Steroids 1970; 15: 333
   PubMed Web of Science ®Google Scholar
• Burr I M., Grant D B., Sozonenko P C., Kaplan S L., Grumbach M M. Some critical factors in double antibody radioprecipitating sera for measurement of human serum, LH, FSH and HGH. J Clin Endocrinol Metab 1969; 29: 948
   Web of Science ®Google Scholar
• McNeilly A S. Radioimmunoassay of human prolactin. Proceedings of the Royal Society of Medicine 1973; 66: 863
   PubMedGoogle Scholar
• Wiest W G., Paulson J D., Keller D W., Warren J C. Free testosterone concentration in serum: A method for determination. Am J Obstet Gynecol 1978; 130: 321
   PubMedGoogle Scholar
• Bradley J V. Distribution-free statistical tests. Prentice-Hall. 1968; 76
   Google Scholar
• Metropolitan Life Insurance Company: Frequence of overweight and underweight. Stat Bull Metrop Life Insur Co 1960; 41: 4
   Google Scholar
• Ylistalo P, Laakso L, Viinikka L, Yliorkola O, Vihko R. Cyproterone acetate in the treatment of hirsutism. Acta Obstet Gynecol Scand 1981; 60: 399
   Google Scholar
• Cumming D C., Yang J C., Rebar R W., Yen S SC. Treatment of hirsutism with spironolactone. JAMA 1982; 247(9)1295
   PubMed Web of Science ®Google Scholar
• Blum I, Bruhis S, Kaufman H. Clinical evaluation of the effects of combined treatment with bromocriptine and spironolactone in two women with the polycystic ovary syndrome. Fertil Steril 1981; 35(6)629
   Google Scholar
• Vigersky R A., Mehlman I, Glass A R., Smith C E. Treatment of hirsute women with cimetidine: A preliminary report. N Engl J Med 1980; 30: 1042
   Google Scholar
• Rodriquez-Rigau L J., Smith K D., Tcholakian R, Steinberger E. Effect of prednisone on plasma testosterone levels and on duration of phases of the menstrual cycle in hyperandrogenic women. Fertil Steril 1979; 32: 408
   Google Scholar
• Lobo R A., Granger L, Goebelsman U, Mishell J R. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab 1981; 52(1)156
   Google Scholar
• Lunde O. Hyperprolactinemia in polycystic ovary syndrome. Ann Chir et Gynecol 1981; 70: 197
   PubMedGoogle Scholar
• Falacho P, Frajese G, Rocco A, Toscano V, Sciarra F. Polycystic ovary syndrome and hyperprolactinemia. J Steroid Biochem 1977; 8: 13
   Google Scholar
• Cullberg G, Knutsson F, Lindstedt G, Mattson L-Å, Steffensen K. Ethinylestradiol and a new progestogen (desogestrel) in a low-dose combination. Effects on pituitary-gonadal function, serum sex-hormone binding globulin capacity, endometrium and cervical mucus. Acta Obstet Gynecol Scand 1982, Suppl. 111: 29
   Google Scholar
• Koninckx P. Stress hyperprolactinemia in clinical practice. Lancet 1978; 1: 273
   Google Scholar
• el Makzangy M N., Wynn V, Lawrence D M. Sex hormone binding globulin capacity as an index of oestroge-nicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39
   Google Scholar
• Lew E A., Garfinkel L. Variations in mortality by weight among 750000 men and women. J Chron Dis 1979; 32: 563
   PubMedGoogle Scholar
• Bates G W., Whitworth N S. Effect of body weight reduction in obese, infertile women. Fertil Steril 1982; 38(4)406
   Google Scholar
• Jackson R L., Dockerty M B. The Stein-Leventhal syndrome. Analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1975; 73: 161
   Google Scholar